» Articles » PMID: 37461514

Molecular Mechanism of a FRET Biosensor for the Cardiac Ryanodine Receptor Pathologically Leaky State

Overview
Journal bioRxiv
Date 2023 Jul 18
PMID 37461514
Authors
Affiliations
Soon will be listed here.
Abstract

Ca leak from cardiomyocyte sarcoplasmic reticulum (SR) via hyperactive resting cardiac ryanodine receptor channels (RyR2) is pro-arrhythmic. An exogenous peptide, (DPc10) detects leaky RyR2 in cardiomyocytes. Conversely, calmodulin (CaM) inhibits RyR2 leak. These observations have led to designing a FRET biosensor for drug discovery targeting RyR2. Here we used FRET to understand the molecular mechanism driving the DPc10-CaM interdependence when binding RyR2 in SR vesicles. We used donor-FKBP12.6 (D-FKBP) to resolve RyR2 binding of acceptor-CaM (A-CaM). In low nanomolar Ca , DPc10 decreased both FRET (under saturating [A-CaM]) and the CaM/RyR2 binding affinity. In micromolar Ca , DPc10 decreased FRET without affecting CaM/RyR2 binding affinity. This correlates with analysis of fluorescence-lifetime-detected FRET indicating that DPc10 lowers occupancy of the RyR2 CaM-binding sites in nanomolar (not micromolar) Ca and lengthens D-FKBP/A-CaM distances independent of [Ca ]. To observe DPc10/RyR2 binding, we used acceptor-DPc10 (A-DPc10). CaM weakens A-DPc10/RyR2 binding, this effect being larger in micromolar vs. nanomolar Ca . Moreover, A-DPc10/RyR2 binding is cooperative in CaM- and FKBP-dependent manner, suggesting that both endogenous modulators promote concerted structural changes between RyR2 protomers for channel regulation. Aided by analysis of cryo-EM structures, these insights inform further development of the DPc10-CaM paradigm for therapeutic discovery targeting RyR2.

References
1.
Dhindwal S, Lobo J, Cabra V, Santiago D, Nayak A, Dryden K . A cryo-EM-based model of phosphorylation- and FKBP12.6-mediated allosterism of the cardiac ryanodine receptor. Sci Signal. 2017; 10(480). DOI: 10.1126/scisignal.aai8842. View

2.
Dong X, Thomas D . Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation. Biochem Biophys Res Commun. 2014; 449(2):196-201. PMC: 4054823. DOI: 10.1016/j.bbrc.2014.04.166. View

3.
Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H . Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circ Res. 2010; 106(8):1413-24. PMC: 2862146. DOI: 10.1161/CIRCRESAHA.109.209312. View

4.
Balshaw D, Xu L, Yamaguchi N, Pasek D, Meissner G . Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem. 2001; 276(23):20144-53. DOI: 10.1074/jbc.M010771200. View

5.
Yamamoto T, Ikemoto N . Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem Biophys Res Commun. 2002; 291(4):1102-8. DOI: 10.1006/bbrc.2002.6569. View